Suppr超能文献

乳腺癌患者乳腺脂肪组织中的冠状结构:与CD68表达、肥胖、代谢因素及预后的关联

Crown-like structures in breast adipose tissue of breast cancer patients: associations with CD68 expression, obesity, metabolic factors and prognosis.

作者信息

Chang Martin C, Eslami Zohreh, Ennis Marguerite, Goodwin Pamela J

机构信息

University of Vermont Cancer Center, Burlington, VT, USA.

Department of Pathology & Laboratory Medicine, Larner College of Medicine at the University of Vermont, Burlington, VT, USA.

出版信息

NPJ Breast Cancer. 2021 Jul 22;7(1):97. doi: 10.1038/s41523-021-00304-x.

Abstract

Crown-like structures of the breast (CLS-B), defined by the clustering of macrophages (identified using CD68 immunohistochemical staining) to surround a dying adipocyte, are a sign of adipose-tissue inflammation. In human cohorts, CLS-B positively correlates with older age, obesity, dyslipidemia and higher levels of glucose, insulin, C-reactive protein and IL-6. In an existing cohort of early-stage breast cancer patients, CLS-B were identified using H&E stained histologic sections (hCLS-B), and by CD68 immunohistochemistry (CD68 + CLS-B). We examined associations of H&E and CD68-detected CLS-B with clinicopathologic features using χ tests, with metabolic factors using Wilcoxon rank sum tests and with disease free and overall survival using Cox regression models. hCLS-B were detected in 59 of 163 patients with slides (36.2%) and CD68 + CLS-B in 37 of 119 patients with paraffin blocks (31.1%). hCLS-B were positively correlated with higher weight (p = 0.003), BMI (p = 0.0008) and C-reactive protein (p = 0.045). CD68 + CLS-B were positively correlated with higher weight (p = 0.006), BMI p = 0.001), leptin (p = 0.034), insulin (p = 0.008) and Homeostasis Model Assessment (p = 0.027). CD68 + CLS-B were associated with poor distant disease-free with a hazard ratio (HR) of 2.81, 95% confidence interval (CI) 1.20-6.57, and overall survival with HR 3.97 (1.66-9.48), while hCLS-B were not associated with either: HR for distant recurrence 0.59 (0.26-1.30); HR for death 1.04 (0.50-2.16). The presence of hCLS-B and of CD68 + CLS-B were associated with obesity; CD68 + CLS-B were associated with insulin resistance and adverse prognosis. Similar patterns were not seen for hCLS-B. Research is needed to understand the biologic basis for these differences.

摘要

乳腺冠状结构(CLS-B)由巨噬细胞(通过CD68免疫组化染色鉴定)聚集环绕死亡脂肪细胞构成,是脂肪组织炎症的标志。在人类队列中,CLS-B与年龄较大、肥胖、血脂异常以及较高水平的葡萄糖、胰岛素、C反应蛋白和白细胞介素-6呈正相关。在一组现有的早期乳腺癌患者队列中,通过苏木精-伊红(H&E)染色组织切片(hCLS-B)以及CD68免疫组化(CD68+CLS-B)来识别CLS-B。我们使用χ检验研究H&E和CD68检测到的CLS-B与临床病理特征的关联,使用Wilcoxon秩和检验研究其与代谢因素的关联,使用Cox回归模型研究其与无病生存期和总生存期的关联。在163例有切片的患者中,59例(36.2%)检测到hCLS-B;在119例有石蜡块的患者中,37例(31.1%)检测到CD68+CLS-B。hCLS-B与较高体重(p=0.003)、体重指数(BMI)(p=0.0008)和C反应蛋白(p=0.045)呈正相关。CD68+CLS-B与较高体重(p=0.006)、BMI(p=0.001)、瘦素(p=0.034)、胰岛素(p=0.008)和稳态模型评估(p=0.027)呈正相关。CD68+CLS-B与远处无病生存不良相关,风险比(HR)为2.81,95%置信区间(CI)为1.20 - 6.57,与总生存期相关,HR为3.97(1.66 - 9.48),而hCLS-B与两者均无关联:远处复发HR为0.59(0.26 - 1.30);死亡HR为1.04(0.50 - 2.16)。hCLS-B和CD68+CLS-B的存在均与肥胖相关;CD68+CLS-B与胰岛素抵抗及不良预后相关。hCLS-B未观察到类似模式。需要开展研究以了解这些差异的生物学基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fbef/8298396/673fb518b1ec/41523_2021_304_Fig1_HTML.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验